Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6696477B2 · kind B2 · utility
1Cited by
32References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2001 |
| Grant date | Feb 24, 2004 |
| Priority date | — |
| Expiry date | Nov 29, 2021 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB64C2027/004
- WIPO fieldTransport
- WIPO sectorMechanical engineering
Abstract
This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating disorders mediated by cyclooxygenase-2 or 5-lipoxygenase, such as inflammation. Compounds of particular interest are defined by Formula I wherein A, Y, R1, R2, R3, R4 and R5 are as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.